positions available now

Tag Archives: PBAC Meeting

Public Submissions to the August 2018 PBAC Special Meeting – Part 2

In the second part of this two-part series (Read Part 1 about here) we bring you further insight into opinions from the public submissions to the August 2018 PBAC Special Meeting. Opinions from the Public Submissions Outcomes of the PBAC’s … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 2

Public Submissions to the August 2018 PBAC Special Meeting – Part 1

In the first of a two-part series, we provide insights into opinions from 28 public submissions to the August 2018 PBAC Special Meeting held on 17 August 2018 regarding considerations for PD-1 and PD-L1 checkpoint inhibitors for multiple cancer types … Continue reading

Posted in Market Access, PBAC, PBS, Uncategorized | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 1

PBAC Special Meeting – August 2018

The August 2018 PBAC special meeting is scheduled for 17 August 2018 to consider options for listing PD-1 and PD-L1 checkpoint inhibitors for the treatment of multiple tumours (pan-tumour indications) on the PBS. Here, the Commercial Eyes Market Access team … Continue reading

Posted in Market Access, PBAC | Tagged , , , , , | Comments Off on PBAC Special Meeting – August 2018

The long road to PBS listing for Orkambi

Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , | Comments Off on The long road to PBS listing for Orkambi

PBAC Meeting Agenda – July 2018

The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting.     The Commercial … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , , , | Comments Off on PBAC Meeting Agenda – July 2018
Copyright © 2014 Commercial Eyes